News
2h
Zacks.com on MSNEXEL Q2 Earnings Top, Sales Miss on Lower Collaboration Revenues
EXEL beats on Q2 earnings but misses revenues as lower collaboration income offsets strong Cabometyx sales growth.
Exelixis Inc (EXEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Challenges
Exelixis Inc (EXEL) reports robust financial results driven by the cabozantinib franchise, while navigating competitive and ...
FourKites has announced some significant AI-powered improvements to its platform for European customers. It has made ...
Q3 2024-2025 revenue down 10.9% Growth maintained in Leisure and Industry, with a persistent decline in agriculture Q3 sales(April 2025–June 2025)) 2023-2024 2024-2025 Change (reported) Change (LFL*) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results